Sex; age at exposure, yr | Age at outcome, yr | Cancer site | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Esophagus | Pancreas | Colorectum | Kidney | Gall bladder | Breast | Endometrium | ||||||||||||||||
Obs. | PAR, % | EAC | Obs. | PAR, % | EAC | Obs. | PAR, % | EAC | Obs. | PAR, % | EAC | Obs. | PAR, % | EAC | Obs. | PAR. % | EAC | Obs. | PAR, % | EAC | ||
Men | ||||||||||||||||||||||
18-34 | 28-44 | < 5 | 26.3 | < 5 | 5 | 4.2 | 0 | 39 | 13.4 | 5 | 28 | 13.4 | 4 | 0 | 5.3 | 0 | ||||||
35-44 | 45-54 | 20 | 31.8 | 6 | 19 | 5.4 | 1 | 125 | 16.8 | 21 | 56 | 16.9 | 9 | < 5 | 6.8 | < 5 | ||||||
45-54 | 55-64 | 38 | 32.4 | 12 | 33 | 5.8 | 2 | 301 | 18.1 | 54 | 109 | 17.2 | 19 | < 5 | 7.0 | < 5 | ||||||
55-64 | 65-74 | 25 | 32.0 | 8 | 50 | 5.6 | 3 | 304 | 17.6 | 54 | 79 | 17.1 | 13 | 6 | 7.0 | < 5 | ||||||
65-74 | 75-84 | 17 | 30.1 | 5 | 48 | 5.6 | 3 | 264 | 17.3 | 46 | 48 | 15.7 | 8 | 12 | 6.3 | 1 | ||||||
≥ 75 | ≥ 85 | 6 | 27.9 | 2 | 17 | 4.6 | 1 | 74 | 14.4 | 11 | 6 | 14.5 | 1 | < 5 | 5.8 | < 5 | ||||||
Total | < 111 | < 38 | 172 | 9 | 1107 | 191 | 326 | 54 | 24 | 2 | ||||||||||||
Women | ||||||||||||||||||||||
18-34 | 28-44 | < 5 | 17.1 | < 5 | < 5 | 4.5 | 0 | 37 | 3.4 | 1 | 14 | 11.7 | 2 | < 5 | 19.6 | < 5 | 26 | 19.6 | 5 | |||
35-44 | 45-54 | < 5 | 24.5 | < 5 | 26 | 5.8 | 1 | 108 | 4.4 | 5 | 28 | 17.2 | 5 | < 5 | 27.6 | < 5 | 83 | 27.6 | 23 | |||
45-54 | 55-64 | 6 | 26.8 | 2 | 42 | 7.1 | 3 | 179 | 5.4 | 10 | 41 | 18.9 | 8 | 7 | 30.1 | 2 | 577 | 7.1 | 41 | 195 | 30.1 | 59 |
55-64 | 65-74 | < 5 | 30.5 | < 5 | 54 | 9.1 | 5 | 198 | 6.9 | 14 | 40 | 21.9 | 9 | 9 | 34.1 | 3 | 541 | 9.1 | 49 | 127 | 34.1 | 43 |
65-74 | 75-84 | 0 | 28.6 | 0 | 60 | 8.4 | 5 | 214 | 6.4 | 14 | 22 | 20.4 | 4 | 8 | 32.0 | 3 | 321 | 8.4 | 27 | 55 | 32.0 | 18 |
≥ 75 | ≥ 85 | 0 | 24.4 | 0 | 25 | 6.2 | 2 | 112 | 4.7 | 5 | 11 | 17.2 | 2 | < 5 | 27.6 | < 5 | 106 | 6.2 | 7 | 18 | 27.6 | 5 |
Total | < 15 | < 5 | < 212 | 16 | 848 | 48 | 156 | 29 | 31 | 10 | 1545 | 124 | 504 | 153 | ||||||||
Total | ||||||||||||||||||||||
18-34 | 28-44 | 5 | 24.4 | 1 | < 10 | 4.2 | 0 | 76 | 8.5 | 6 | 42 | 12.8 | 5 | < 5 | 19.6 | < 5 | 26 | 19.6 | 5 | |||
35-44 | 45-54 | < 25 | 30.6 | < 10 | 45 | 5.6 | 3 | 233 | 11.1 | 26 | 84 | 17.0 | 14 | < 10 | 20.7 | < 5 | 83 | 27.6 | 23 | |||
45-54 | 55-64 | 44 | 31.3 | 14 | 75 | 6.6 | 5 | 480 | 13.4 | 64 | 150 | 17.7 | 27 | < 12 | 25.0 | 2 | 577 | 7.1 | 41 | 195 | 30.1 | 59 |
55-64 | 65-74 | < 30 | 31.8 | < 10 | 104 | 7.4 | 8 | 502 | 13.4 | 67 | 119 | 18.7 | 22 | 15 | 23.2 | 3 | 541 | 9.1 | 49 | 127 | 34.1 | 43 |
65-74 | 75-84 | 17 | 29.9 | 5 | 108 | 7.1 | 8 | 478 | 12.4 | 59 | 70 | 17.2 | 12 | 20 | 16.6 | 3 | 321 | 8.4 | 27 | 55 | 32.0 | 18 |
≥ 75 | ≥ 85 | 6 | 27.0 | 2 | 42 | 5.6 | 2 | 186 | 8.6 | 16 | 17 | 16.2 | 3 | < 5 | 16.7 | < 5 | 106 | 6.2 | 7 | 18 | 27.6 | 5 |
Total | 123 | 38 | < 384 | 25 | 1955 | 239 | 482 | 83 | 55 | 11 | 1545 | 124 | 504 | 153 |
Note: EAC = excess attributable cases due to exposure, Obs. = total number of observed cases per age-sex group, PAR = population attributable risk.
*Cell counts of less than 5 for observed cases were suppressed to comply with confidentiality requirements.
†95% confidence intervals for the population attributable risk estimates are presented in Appendix 1, Supplementary Table 2.